Bigworld, I see you recently posted over on a biotech board (PPHM). I hadn't realized that you followed the sector, although it figures since you're a clinical pharmacist.
I've been following biotech off and on for years, but it's such a tough sector, between the highly specialized science, the many competing programs, seemingly endless stock dilution, etc.
In the beginning it seems that every bio investor falls in love with a particular stock, but then experiences a painful lesson in the mega risks involved. That happened to me several times, but the amazing science always seems to lure me back.
News 
Market Data 
Discover 
AI
